Neuron-specific enolase (NSE) is currently considered a useful marker in the diagnosis, prognosis, and follow-up of related neuroendocrine tumors (Zeltzer et al., 1983; Shine et al., 1990; Giovanella et al., 1995). Here, ENO2 is linked to neuroendocrine neoplasm.